Patents by Inventor MingLiang Ma

MingLiang Ma has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220298601
    Abstract: The present disclosure belongs to the technical field of wave absorbing materials, and discloses a one-dimensional coralloid NiS/Ni3S4@PPy@MoS2-based wave absorber, and a preparation method and use thereof. A preparation method of a one-dimensional coralloid NiS/Ni3S4@PPy@MoS2-based wave absorber includes the following steps. Preparing one-dimensional Ni nanowires by a reduction method. Coating a layer of polypyrrole (PPy) on the Ni nanowires by an in-situ polymerization method using pyrrole as a monomer, to obtain Ni@PPy nanowires. Coating MoS2 nanorods on the Ni@PPy nanowires by a hydrothermal synthesis method. Meanwhile, Ni as a sacrificial template is vulcanized into NiS/Ni3S4 to prepare the one-dimensional coralloid NiS/Ni3S4@PPy@MoS2-based wave absorber. The wave absorber has a novel surface morphology and simple preparation process.
    Type: Application
    Filed: March 14, 2022
    Publication date: September 22, 2022
    Applicant: Qingdao University of Technology
    Inventors: Mingliang Ma, Yanyan Liu, Zhouyu Tong, Zijian Liao, Yan Chen, Rongzhen Wang
  • Patent number: 9371263
    Abstract: Disclosed herein are compounds, compositions and methods for preventing and treating diseases such as intracerebral hemorrhage, cancer, or conditions associated with damaged cells, activated lymphocytes, or microbial products. The disclosed compounds are curcumin analogs. The curcumin analogs possess anti-inflammatory and antioxidant properties, which in part, reduce AP-1 and NF-?B activity.
    Type: Grant
    Filed: September 22, 2014
    Date of Patent: June 21, 2016
    Assignees: Augusta University Research Institute, Inc., East China Normal University
    Inventors: Cargill H. Alleyne, Jr., Krishnan M. Dhandapani, Ken Wen, MingLiang Ma, WenJing Hu
  • Publication number: 20150087705
    Abstract: Disclosed herein are compounds, compositions and methods for preventing and treating diseases such as intracerebral hemorrhage, cancer, or conditions associated with damaged cells, activated lymphocytes, or microbial products. The disclosed compounds are curcumin analogs. The curcumin analogs possess anti-inflammatory and antioxidant properties, which in part, reduce AP-1 and NF-?B activity.
    Type: Application
    Filed: September 22, 2014
    Publication date: March 26, 2015
    Inventors: Cargill H. Alleyne, JR., Krishnan M. Dhandapani, Ken Wen, MingLiang Ma, WenJing Hu